GTS5:Volunteer Assignments and Opportunities: Difference between revisions
Richard.Glen (talk | contribs) m Formatted Author Names |
No edit summary |
||
| (9 intermediate revisions by 4 users not shown) | |||
| Line 75: | Line 75: | ||
|[[GTS5:Hereditary_neuroblastoma_(ALK,_PHOX2B)|Hereditary neuroblastoma (ALK, PHOX2B)]] | |[[GTS5:Hereditary_neuroblastoma_(ALK,_PHOX2B)|Hereditary neuroblastoma (ALK, PHOX2B)]] | ||
|Disease | |Disease | ||
|Fareeda Brohi MBBS (trainee), Eric McGinnis | |||
|2/26/2026 | |||
| | | | ||
|PENDING | |||
| | | | ||
| | |Eric McGinnis | ||
| | | | ||
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content. | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content. | ||
| Line 175: | Line 175: | ||
|[[GTS5:Noonan_syndrome_(Various_genes)|Noonan syndrome (Various genes)]] | |[[GTS5:Noonan_syndrome_(Various_genes)|Noonan syndrome (Various genes)]] | ||
|Disease | |Disease | ||
|Suranjana Banik | |||
|3/5/2026 | |||
| | | | ||
|PENDING | |||
| | | | ||
| | |Eric McGinnis | ||
| | | | ||
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content. | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content. | ||
| Line 322: | Line 322: | ||
|Jasmine Baker, PhD | |Jasmine Baker, PhD | ||
|08/25/2025 | |08/25/2025 | ||
| | |12/31/2025 | ||
| | | | ||
| | | | ||
| Line 408: | Line 408: | ||
|[[GTS5:Tuberous_sclerosis_(TSC1,_TSC1)|Tuberous sclerosis (TSC1, TSC1)]] | |[[GTS5:Tuberous_sclerosis_(TSC1,_TSC1)|Tuberous sclerosis (TSC1, TSC1)]] | ||
|Disease | |Disease | ||
|Faisel Ibrahim | |||
|1/20/2026 | |||
| | | | ||
|PENDING | |||
| | | | ||
| | |Eric McGinnis | ||
| | | | ||
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO MALE5, CNS5, PEDS5, HAN5. | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO MALE5, CNS5, PEDS5, HAN5. | ||
| Line 648: | Line 648: | ||
|[[GTS5:CDK4-related_melanoma_predisposition_syndrome_(CDK4)|CDK4-related melanoma predisposition syndrome (CDK4)]] | |[[GTS5:CDK4-related_melanoma_predisposition_syndrome_(CDK4)|CDK4-related melanoma predisposition syndrome (CDK4)]] | ||
|Disease | |Disease | ||
|Xiaolin Hu | |||
|12/9/2025 | |||
| | | | ||
|PENDING | |||
| | | | ||
| | |Eric McGinnis | ||
| | | | ||
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content. | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content. | ||
| Line 659: | Line 659: | ||
|[[GTS5:Autoimmune_lymphoproliferative_syndrome_(FAS)|Autoimmune lymphoproliferative syndrome (FAS)]] | |[[GTS5:Autoimmune_lymphoproliferative_syndrome_(FAS)|Autoimmune lymphoproliferative syndrome (FAS)]] | ||
|Disease | |Disease | ||
|Aviv Oren, MD (trainee); | |||
Karin Miller, MD | |||
|3/25/2024 | |||
| | | | ||
|Pending | |||
| | | | ||
| | |SK | ||
| | | | ||
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO HAEM5. | |Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO HAEM5. | ||
| Line 727: | Line 728: | ||
|[[GTS5:BRCA-related_cancer_predisposition_syndrome_(BRCA1,_BRCA2)|BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]] | |[[GTS5:BRCA-related_cancer_predisposition_syndrome_(BRCA1,_BRCA2)|BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]] | ||
|Disease | |Disease | ||
| | |Parisa Kargaran | ||
|9/ | |1/9/26 | ||
| | |1/16/2026 | ||
| | |COMPLETE | ||
| | | | ||
|Katherine Geiersbach | |Katherine Geiersbach | ||
| Line 738: | Line 739: | ||
|[[GTS5:PALB2-related_cancer_predisposition_syndrome_(PALB2)|PALB2-related cancer predisposition syndrome (PALB2)]] | |[[GTS5:PALB2-related_cancer_predisposition_syndrome_(PALB2)|PALB2-related cancer predisposition syndrome (PALB2)]] | ||
|Disease | |Disease | ||
|Hieu Nguyen | |Parisa Kargaran, Hieu Nguyen | ||
|9/23/2025 | |9/23/2025 | ||
| | |1/16/2026 | ||
| | |COMPLETE | ||
| | | | ||
|Katherine Geiersbach | |Katherine Geiersbach | ||
| Line 749: | Line 750: | ||
|[[GTS5:RAD51-related_cancer_predisposition_syndrome_(RAD51C,_RAD51D)|RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]] | |[[GTS5:RAD51-related_cancer_predisposition_syndrome_(RAD51C,_RAD51D)|RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]] | ||
|Disease | |Disease | ||
|Xiaolin Hu | |||
|12/9/2025 | |||
| | | | ||
|PENDING | |||
| | | | ||
| | |Eric McGinnis | ||
| | | | ||
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content. | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content. | ||
| Line 815: | Line 816: | ||
|[[GTS5:Xeroderma_Pigmentosum|Xeroderma Pigmentosum]] | |[[GTS5:Xeroderma_Pigmentosum|Xeroderma Pigmentosum]] | ||
|Disease | |Disease | ||
|Suranjana Banik | |||
|3/5/2026 | |||
| | | | ||
|PENDING | |||
| | | | ||
| | |Eric McGinnis | ||
| | | | ||
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO SKIN5, PEDS5. | |Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO SKIN5, PEDS5. | ||
| Line 826: | Line 827: | ||
|[[GTS5:Ataxia-telangiectasia_syndrome_(ATM)|Ataxia-telangiectasia syndrome (ATM)]] | |[[GTS5:Ataxia-telangiectasia_syndrome_(ATM)|Ataxia-telangiectasia syndrome (ATM)]] | ||
|Disease | |Disease | ||
|Emilie Lalonde | |||
|12/16/2025 | |||
| | | | ||
|PENDING | |||
| | | | ||
| | |Katherine Geiersbach (Eric McGinnis as needed) | ||
| | | | ||
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24 to page created on 7/12/24. Also, content in online WHO HAEM5, HAN5, FEM5, BRST5. | |Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24 to page created on 7/12/24. Also, content in online WHO HAEM5, HAN5, FEM5, BRST5. | ||
| Line 993: | Line 994: | ||
|[[GTS5:Dyskeratosis_congenita_(DKC1,_TERT,_TERC,_TINF2,_Other_IBMFS_genes)|Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)]] | |[[GTS5:Dyskeratosis_congenita_(DKC1,_TERT,_TERC,_TINF2,_Other_IBMFS_genes)|Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)]] | ||
|Disease | |Disease | ||
|Parisa Kargaran | |||
|1/21/2026 | |||
| | | | ||
|PENDING | |||
| | | | ||
| | |Katherine Geiersbach | ||
| | | | ||
|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO EYE5, HAN5. | |Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO EYE5, HAN5. | ||
| Line 1,004: | Line 1,005: | ||
|[[GTS5:POT1_and_Shelterin-related_tumour_predisposition_syndrome_(POT1,_ACD,_TERF2IP,_TERT_promoter)|POT1 and Shelterin-related tumour predisposition syndrome (POT1, ACD, TERF2IP, TERT promoter)]] | |[[GTS5:POT1_and_Shelterin-related_tumour_predisposition_syndrome_(POT1,_ACD,_TERF2IP,_TERT_promoter)|POT1 and Shelterin-related tumour predisposition syndrome (POT1, ACD, TERF2IP, TERT promoter)]] | ||
|Disease | |Disease | ||
|Parisa Kargaran | |||
|1/21/2026 | |||
| | | | ||
|PENDING | |||
| | | | ||
| | |Katherine Geiersbach | ||
| | | | ||
|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content. | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content. | ||